Prevalence and virological profiles of hepatitis B infection in human immunodeficiency virus patients.
about
Detection of highly prevalent hepatitis B virus co-infection with HIV in Indonesia.Epidemiology, risk factors and genotypes of HBV in HIV-infected patients in the northeast region of Colombia: high prevalence of occult hepatitis B and F3 subgenotype dominanceOccult hepatitis B virus co-infection in human immunodeficiency virus-positive patients: A review of prevalence, diagnosis and clinical significance.Broad Range of Hepatitis B Virus (HBV) Patterns, Dual Circulation of Quasi-Subgenotype A3 and HBV/E and Heterogeneous HBV Mutations in HIV-Positive Patients in GabonA Cross Section Study to Determine the Prevalence of Antibodies against HIV Infection among Hepatitis B and C Infected Individuals.HIV/HBV coinfection in children and antiviral therapy.Slow CD4+ T-Cell Recovery in Human Immunodeficiency Virus/Hepatitis B Virus-Coinfected Patients Initiating Truvada-Based Combination Antiretroviral Therapy in Botswana.A Comparison of Hepatitis B Virus Infection in HIV-infected and HIV-uninfected Participants Enrolled in a Multi-National Clinical Trial: HPTN 052.Serological markers of hepatitis B and C in patients with HIV/AIDS and active tuberculosis.HIV-hepatitis B virus co-infection: epidemiology, pathogenesis, and treatment.Presence of anti-HBc is associated to high rates of HBV resolved infection and low threshold for Occult HBV Infection in HIV patients with negative HBsAg in Chile.Prevalence of hepatitis B markers in Senegalese HIV-1-infected patients.The prevalence of hepatitis B virus infection markers and socio-demographic risk factors in HIV-infected patients in Southern Brazil.The prevalence of hepatitis B virus among HIV-positive patients at Kilimanjaro Christian Medical Centre Referral Hospital, Northern Tanzania.
P2860
Q34556226-3E85CBCA-B4C2-49EB-A19D-91C271878AFEQ34612595-855FE245-10E6-456B-8BAB-3799BD237AC9Q35127050-FBE35144-8DE0-4E82-9A28-24D67EB1C10EQ35893639-38EDE9D1-8588-4A8B-A8C4-131E0CB5C4E6Q36732492-C38C0B28-5AC8-49B2-A072-402482DC9922Q36775147-A0E0DF31-5851-43FC-849E-0FB738E3ECA7Q37375386-CE13849E-C5D2-4377-A379-BBFBC0598C7FQ38657651-C6304674-124A-4602-8D3E-4C567876BD2EQ38878697-46AA20BE-BD3B-4B88-A614-76401FDE613AQ39425755-2DB7D745-E6B6-4E54-8516-927152F9B0CAQ40528258-164C3C9C-1498-4A1C-922A-E4E3ECDB3452Q40648463-07F19278-A5A9-4B2E-9664-C582227860F9Q41623032-A865EED3-A8DB-4BAD-844B-A11DB56A13F2Q55096262-D47B1F78-B296-4127-B619-53BEEEFF01B8
P2860
Prevalence and virological profiles of hepatitis B infection in human immunodeficiency virus patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Prevalence and virological pro ...... munodeficiency virus patients.
@ast
Prevalence and virological pro ...... munodeficiency virus patients.
@en
type
label
Prevalence and virological pro ...... munodeficiency virus patients.
@ast
Prevalence and virological pro ...... munodeficiency virus patients.
@en
prefLabel
Prevalence and virological pro ...... munodeficiency virus patients.
@ast
Prevalence and virological pro ...... munodeficiency virus patients.
@en
P2093
P2860
P356
P1476
Prevalence and virological pro ...... munodeficiency virus patients.
@en
P2093
Catherine Seyler
Eugène Messou
Henri Chenal
Koffi Alain Attia
Myreille Mbamy
Naomi Wakasugi
Sandrine Polneau
Serge Eholié
Thomas Toni
Thérèse N'dri-Yoman
P2860
P304
P356
10.4254/WJH.V4.I7.218
P577
2012-07-01T00:00:00Z